Drugs / EVM16
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06541639 | Mar 2025 → Mar 2028 expected | cancer | Peking University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EVM16 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06541639 ↗ |